X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7890) 7890
Publication (849) 849
Book Review (831) 831
Book Chapter (27) 27
Conference Proceeding (12) 12
Book / eBook (8) 8
Dissertation (7) 7
Magazine Article (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7586) 7586
humans (5823) 5823
aryl hydrocarbon hydroxylases - genetics (4249) 4249
male (3473) 3473
female (3088) 3088
animals (2867) 2867
pharmacology & pharmacy (2545) 2545
aryl hydrocarbon hydroxylases - metabolism (2102) 2102
genotype (2000) 2000
cytochrome p-450 enzyme system - genetics (1941) 1941
aryl hydrocarbon hydroxylases (1729) 1729
adult (1680) 1680
cytochrome p-450 cyp2c19 (1600) 1600
middle aged (1598) 1598
cytochrome p-450 cyp2c9 (1394) 1394
polymorphism, genetic (1340) 1340
mixed function oxygenases - genetics (1302) 1302
cytochrome p-450 enzyme system - metabolism (1299) 1299
metabolism (1297) 1297
cytochrome p-450 (1245) 1245
mice (1168) 1168
aged (1079) 1079
rats (1067) 1067
pharmacogenetics (1024) 1024
biochemistry & molecular biology (981) 981
cytochrome p-450 cyp1b1 (946) 946
toxicology (926) 926
alleles (796) 796
expression (783) 783
cytochrome p450 (782) 782
polymorphism (737) 737
cytochrome p-450 cyp3a (715) 715
pharmacokinetics (692) 692
liver - enzymology (689) 689
mixed function oxygenases - metabolism (663) 663
genetic aspects (655) 655
enzymes (637) 637
dose-response relationship, drug (617) 617
phenotype (591) 591
molecular sequence data (577) 577
steroid hydroxylases - genetics (575) 575
abridged index medicus (569) 569
cytochrome p-450 cyp2a6 (567) 567
base sequence (563) 563
physiological aspects (562) 562
oncology (557) 557
polymorphism, single nucleotide (552) 552
microsomes, liver - enzymology (550) 550
cyp2c9 (549) 549
oxidoreductases, n-demethylating - genetics (538) 538
aryl hydrocarbon hydroxylases - biosynthesis (531) 531
rna, messenger - metabolism (531) 531
identification (525) 525
induction (521) 521
research (514) 514
polymerase chain reaction (513) 513
cyp2c19 (506) 506
cytochrome p-450 cyp1a1 - genetics (505) 505
genetics & heredity (491) 491
analysis (483) 483
gene frequency (482) 482
cytochrome p-450 cyp2b6 (481) 481
cells, cultured (474) 474
hydroxylation (472) 472
in-vitro (470) 470
liver (470) 470
warfarin (469) 469
cytochrome p-450 enzyme system - biosynthesis (462) 462
kinetics (458) 458
liver - metabolism (457) 457
gene expression (451) 451
liver - drug effects (449) 449
article (446) 446
risk factors (445) 445
cytochrome p450 family 2 (438) 438
human liver-microsomes (431) 431
enzyme induction (422) 422
mutation (418) 418
genes (417) 417
adolescent (415) 415
polymorphisms (402) 402
rna, messenger - genetics (401) 401
aryl-hydrocarbon receptor (392) 392
ticlopidine - analogs & derivatives (392) 392
genetic polymorphisms (391) 391
gene-expression (386) 386
enzyme induction - drug effects (381) 381
drug interactions (380) 380
aged, 80 and over (375) 375
steroid hydroxylases - metabolism (374) 374
cancer (365) 365
vitamin k epoxide reductases (361) 361
steroid 16-alpha-hydroxylase (358) 358
oxidoreductases, n-demethylating - metabolism (357) 357
anticoagulants - administration & dosage (354) 354
rats, sprague-dawley (352) 352
warfarin - administration & dosage (351) 351
association (347) 347
risk (344) 344
receptors, aryl hydrocarbon - metabolism (340) 340
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7660) 7660
Chinese (60) 60
Japanese (59) 59
Russian (54) 54
French (18) 18
German (15) 15
Spanish (13) 13
Polish (9) 9
Swedish (5) 5
Czech (3) 3
Danish (3) 3
Hungarian (3) 3
Dutch (2) 2
Italian (2) 2
Korean (2) 2
Norwegian (2) 2
Romanian (2) 2
Hebrew (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drug Metabolism and Disposition, ISSN 0090-9556, 01/2010, Volume 38, Issue 1, pp. 92 - 99
The aim of the current study is to identify the human cytochrome P450 (P450) isoforms involved in the two oxidative steps in the bioactivation of clopidogrel... 
MECHANISM-BASED INHIBITION | ANTIAGGREGATING ACTIVITY | POLYMORPHISMS | TICLOPIDINE | PHARMACOKINETICS | HEALTHY-SUBJECTS | PHARMACOLOGY & PHARMACY | PRASUGREL | PHARMACODYNAMICS | MONOCLONAL-ANTIBODIES | ATORVASTATIN | Microsomes - metabolism | Humans | Aryl Hydrocarbon Hydroxylases - genetics | Cytochrome P-450 Enzyme System - metabolism | Sulfaphenazole - pharmacology | Microsomes - drug effects | Cytochrome P-450 CYP3A - genetics | Cytochrome P-450 CYP1A2 - genetics | Antibodies - immunology | Omeprazole - pharmacology | Microsomes, Liver - enzymology | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Oxidoreductases, N-Demethylating - metabolism | Aryl Hydrocarbon Hydroxylases - immunology | Oxidation-Reduction | Enzyme Inhibitors - pharmacology | Ticlopidine - analogs & derivatives | Oxidoreductases, N-Demethylating - immunology | Cytochrome P-450 CYP3A - metabolism | Cell Line, Tumor | Cytochrome P-450 Enzyme System - genetics | Theophylline - pharmacology | Kinetics | Cytochrome P-450 CYP2C9 | Theophylline - analogs & derivatives | Oxidoreductases, N-Demethylating - genetics | Glutathione - metabolism | Ketoconazole - pharmacology | Biotransformation - physiology | Cytochrome P-450 CYP1A2 Inhibitors | Microsomes, Liver - drug effects | Ticlopidine - metabolism | NADP - metabolism | Platelet Aggregation Inhibitors - metabolism | Cytochrome P-450 CYP3A - immunology | Cell Line | Aryl Hydrocarbon Hydroxylases - antagonists & inhibitors | Cytochrome P-450 CYP1A2 - immunology | Biocatalysis | Mephenytoin - analogs & derivatives | Cytochrome P-450 CYP1A2 - metabolism | Aryl Hydrocarbon Hydroxylases - metabolism | Mephenytoin - pharmacology | Antibodies - pharmacology | Cytochrome P-450 CYP3A Inhibitors | Cytochrome P-450 CYP2C19 | Clopidogrel | Cytochrome P-450 CYP2B6 | Index Medicus
Journal Article
Science, ISSN 0036-8075, 9/2010, Volume 329, Issue 5997, pp. 1345 - 1348
Although practiced clinically for more than 40 years, the use of hematopoietic stem cell (HSC) transplants remains limited by the ability to expand these cells... 
Hep G2 cells | Cytokines | REPORTS | Stem cells | Multipotent stem cells | Bone marrow | Cultured cells | Transplantation | Aryl hydrocarbon receptors | Hematopoietic stem cells | Blood | EX-VIVO EXPANSION | ENGRAFTMENT | MULTIDISCIPLINARY SCIENCES | BONE-MARROW | BIOLOGY | MICE | UMBILICAL-CORD BLOOD | BINDING | TRANSPLANTATION | Antigens, CD34 - analysis | Cell Proliferation | Receptors, Aryl Hydrocarbon - antagonists & inhibitors | Species Specificity | Cell Count | Humans | Aryl Hydrocarbon Hydroxylases - genetics | Antigens, CD - analysis | Multipotent Stem Cells - drug effects | Hematopoiesis | Polychlorinated Dibenzodioxins - pharmacology | Hematopoietic Stem Cells - physiology | Receptors, Aryl Hydrocarbon - metabolism | Multipotent Stem Cells - physiology | Hematopoietic Stem Cells - drug effects | Signal Transduction | Purines - metabolism | Purines - pharmacology | Cells, Cultured | Hematopoietic Stem Cell Transplantation | Hematopoietic Stem Cells - metabolism | Mice, SCID | AC133 Antigen | Aryl Hydrocarbon Hydroxylases - metabolism | Cell Lineage | Animals | Multipotent Stem Cells - cytology | Small Molecule Libraries | Hematopoietic Stem Cells - cytology | Cytochrome P-450 CYP1B1 | Mice, Inbred NOD | Mice | Glycoproteins - analysis | Cytokines - pharmacology | Peptides - analysis | Physiological aspects | Arylation | Human | Receptors | Aromatic compounds | Modulation | Hydrocarbons | Derivatives | Culture | Index Medicus
Journal Article
by Thorgeirsson, T.E and Gudbjartsson, D.F and Surakka, I and Vink, J.M and Amin, N and Geller, F and Sulem, P and Rafnar, T and Esko, T and Walter, S and Gieger, C and Rawal, R and Mangino, M and Prokopenko, I and Magi, R and Keskitalo, K and Gudjonsdottir, I.H and Gretarsdottir, S and Stefansson, H and Thompson, J.R and Aulchenko, Y.S and Nelis, M and Aben, K.K.H and Heijer, M. den and Dirksen, A and Ashraf, H and Soranzo, N and Valdes, A.M and Steves, C and Uitterlinden, A.G and Hofman, A and Tonjes, A and Kovacs, P and Hottenga, J.J and Willemsen, G and Vogelzangs, N and Doring, A and Dahmen, N and Nitz, B and Pergadia, M.L and Saez, B and Diego, V. De and Lezcano, V and Garcia-Prats, M.D and Ripatti, S and Perola, M and Kettunen, J and Hartikainen, A.L and Pouta, A and Laitinen, J and Isohanni, M and Huei-Yi, S and Allen, M and Krestyaninova, M and Hall, A.S and Jones, G.T and Rij, A.M. van and Mueller, T and Dieplinger, B and Haltmayer, M and Jonsson, S and Matthiasson, S.E and Oskarsson, H and Tyrfingsson, T and Kiemeney, L.A.L.M and Mayordomo, J.I and Lindholt, J.S and Pedersen, J.H and Franklin, W.A and Wolf, H and Montgomery, G.W and Heath, A.C and Martin, N.G and Madden, P.A.F and Giegling, I and Rujescu, D and Jarvelin, M.R and Salomaa, V and Stumvoll, M and Spector, T.D and Wichmann, H.E and Metspalu, A and Samani, N.J and Penninx, B.W.J.H and Oostra, B.A and Boomsma, D.I and Tiemeier, H and Duijn, C.M. van and Kaprio, J and Gulcher, J.R and McCarthy, M.I and Peltonen, L and Thorsteinsdottir, U and Stefansson, K and ENGAGE Consortium and The ENGAGE Consortium
Nature Genetics, ISSN 1061-4036, 2010, Volume 42, Issue 5, pp. 448 - 453
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2009, Volume 360, Issue 4, pp. 363 - 375
In a cohort of 2208 patients who presented with acute myocardial infarction and were treated with clopidogrel, single-nucleotide polymorphisms in five genes... 
ST-ELEVATION | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | DUODENAL ENTEROCYTES | OF-FUNCTION POLYMORPHISM | SEQUENCE VARIATIONS | MDR1 GENE | DRUG RESPONSE | ASPIRIN | ELEVATION MYOCARDIAL-INFARCTION | P-GLYCOPROTEIN | Myocardial Infarction - genetics | Myocardial Infarction - epidemiology | Follow-Up Studies | Ticlopidine - pharmacology | Ticlopidine - therapeutic use | Humans | Middle Aged | Aryl Hydrocarbon Hydroxylases - genetics | Male | Angioplasty, Balloon, Coronary | Myocardial Infarction - therapy | Cytochrome P-450 CYP3A - genetics | Receptors, Purinergic P2 - genetics | Receptors, Purinergic P2Y12 | Ticlopidine - adverse effects | Platelet Aggregation Inhibitors - pharmacology | Female | Integrin beta3 - genetics | Registries | Stroke - epidemiology | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Mortality | Genotype | Combined Modality Therapy | Ticlopidine - analogs & derivatives | Aryl Hydrocarbon Hydroxylases - metabolism | Polymorphism, Genetic | ATP-Binding Cassette, Sub-Family B, Member 1 - genetics | Cytochrome P-450 CYP2C19 | ATP Binding Cassette Transporter, Sub-Family B | Aged | Mutation | Complications and side effects | Usage | Analysis | Clopidogrel | Cardiovascular diseases | Genetic polymorphisms | Risk factors | Heart attacks | Biomedical research | Angina pectoris | Acute coronary syndromes | Kinases | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2013, Volume 369, Issue 24, pp. 2283 - 2293
Journal Article
Science, ISSN 0036-8075, 2014, Volume 343, Issue 6175, pp. 1118 - 1118
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 08/2004, Volume 279, Issue 34, pp. 35630 - 35637
Journal Article
Nature, ISSN 0028-0836, 07/2003, Volume 424, Issue 6947, pp. 464 - 468
Journal Article
Journal Article